Agency Business briefs: December 2012

Share this article:
Kimberly Clotman
Kimberly Clotman

Roska Healthcare Advertising named Kimberly Clotman EVP director of client services. Clotman, previously SVP, will sit on the Montgomeryville, PA-based shop's executive committee.

Advertising and media companies cited sluggish adspend in the pharma sector, among others, in reporting generally disappointing third-quarter earnings last month, saying that marketers cut back in September, amid political uncertainty in the US and economic uncertainty in Europe. Interpublic's Michael Roth told analysts that “until this macro uncertainty is removed, I think we can't say with certainty what the outcome is going to be.”

Dudnyk has landed new business from Nicox in support of its AdenoPlus launch. The Horsham, PA-based agency will work on promotion of the point-of-care pink-eye diagnostic to eye-care professionals.

New Jersey health advertising shop Lanmark360 responded to Hurricane Sandy with a “Shave the Shore” Facebook pledge drive in which president Howard Klein has vowed not to shave until he raises at least $10,000 for disaster relief. All donations will go to American Red Cross Sandy relief efforts.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?